Rifampicin Shows Antiviral Action By Blocking Virus Membranes
NIH researchers report rifampicin disrupts viral membrane formation in infected cells, preventing assembly of vaccinia virus particles. The antibiotic's selective action harms viruses more than human cells and may guide new antiviral developments and derivatives for other virus classes.